Self-Testing Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The self-testing market size has grown rapidly in recent years. It will grow from $15.28 billion in 2024 to $16.9 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to educational reform movements, scientific inquiry and the enlightenment, industrial revolution, healthcare and preventive medicine, psychometric testing and personality assessment.

The self-testing market size is expected to see rapid growth in the next few years. It will grow to $24.99 billion in 2029 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to advancements in personalized medicine, rise of telehealth and remote monitoring, growing demand for mental health support, expansion of wearable health tech. Major trends in the forecast period include point-of-care testing, blockchain-enabled data security, personalized wellness ecosystems, biohacking and quantified self-movements.

The rising prevalence of chronic diseases is expected to drive the growth of the self-testing market in the coming years. Chronic diseases are long-lasting medical conditions that typically progress slowly and persist over time. These diseases are influenced by factors such as demographic changes, lifestyle habits, environmental conditions, and advancements in healthcare. Self-testing is increasingly utilized in the management of chronic diseases, helping individuals actively monitor their health, improve adherence to treatment plans, and detect potential complications or changes in their condition early. For example, a report published by the National Library of Medicine in January 2023 predicted that by 2.05 trillion people in the United States will have at least one chronic illness, representing a 99.5% increase from 71.522 million in 2020. As a result, the growing prevalence of chronic diseases is a key factor driving the expansion of the self-testing market.

Key players in the self-testing market are focused on innovation to enhance convenience, accessibility, and accuracy for users. For example, Pragmatech Healthcare Solutions introduced Cervicheck self-sampling kits in April 2023, offering women a convenient method to screen for the human papillomavirus (HPV), a major contributor to cervical cancer cases. This kit enables women to collect samples at home, addressing concerns about late detection due to reluctance to undergo testing at medical facilities. Featuring self-sampling and point-of-care detection, Cervicheck aims to empower women to detect cervical cancer early, thereby reducing mortality rates and the burden associated with late-stage cancer diagnosis.

In July 2022, Wondfo Biotech Co., Ltd., a China-based company specializing in the development of rapid diagnostic tests and medical devices, partnered with MedAccess to improve access to affordable diagnostics in low- and middle-income countries. This collaboration aims to enhance healthcare accessibility and support the early detection and treatment of diseases. Through this partnership, Wondfo Biotech Co., Ltd. and MedAccess seek to expand the availability of affordable, high-quality diagnostic tests in underserved regions, facilitating timely disease detection and improving health outcomes. MedAccess, a UK-based company, focuses on offering self-testing solutions.

Major companies operating in the self-testing market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, Hologic Inc., PerkinElmer, BioMérieux, Sysmex Corporation, Bio-Rad Laboratories, Quidel Corporation, Cepheid, OraSure Technologies, Meridian Bioscience Inc., Ancestry.com DNA LLC, 23andMe Inc., MyHeritage Ltd., iHealth Labs Inc., Everly Health Inc., Helix OpCo LLC, BioIQ Inc., Veritas Intercontinental Inc., Pathway Genomics Corporation, Vitagene Inc., Orig3n Inc.

North America was the largest region in the self-testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the self-testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The self-testing market consist of revenues earned by entities by providing services such as medical self-testing services, professional skills self-assessment services, medical stimulation services, and fitness and wellness self-testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The self-testing market also includes sales of medical self-testing products, health monitoring wearables, online symptom checkers, home diagnostic kits, personal health monitoring devices, and disease-specific testing kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Self-testing involves individuals conducting tests for specific medical conditions or characteristics using diagnostic tools or kits without the direct oversight of a healthcare professional. These tests enable individuals to monitor their health status, screen for particular conditions, or manage chronic diseases from the comfort of their homes. Self-testing offers benefits such as convenience, privacy, and empowerment for patients.

The primary types of products in self-testing include kits, devices, and strips. Kits typically comprise comprehensive packages containing all the essential materials and instructions required for individuals to collect and analyze their own samples. These kits can be utilized for various sample types, including blood, urine, stool, and others, and are accessible through different distribution channels, such as online and offline platforms. They serve a wide array of applications, including blood glucose testing, pregnancy and fertility testing, cancer screening, drug abuse testing, sexually transmitted disease or sexually transmitted infection testing, cholesterol testing, HIV testing, thyroid testing, among others.

The self-testing market research report is one of a series of new reports that provides self-testing market statistics, including self-testing industry global market size, regional shares, competitors with a self-testing market share, detailed self-testing market segments, market trends and opportunities, and any further data you may need to thrive in the self-testing industry. This self-testing market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.